Organic growth

Organic growth · 05. September 2017
SynAbs widens both technical and business teams to sustain organic growth in custom monoclonal antibodies generation services
Organic growth · 01. June 2017
SynAbs moves to Gosselies Biopark in order to strengthen relationships with players active in immunology, cell therapy and immunohistochemistry providing mAb custom generation, and unique off-the-shelf portfolio of ELISpot, ELISA, anti-CD monoclonal antibodies